Replay the Live...
October 2022 Newsletter
read more
SOPHiA GENETICS Partners with Microsoft to Accelerate Multimodal Health Data Analysis
The agreement is to expand and reinforce data-driven medicine through the SOPHiA DDM™ health data...
Improving Analytics with 1 Million Genomic Profiles
Our platform has analyzed over 1 million genomic profiles, we chatted with some experts to see how this data is helping to improve our knowledge over time.
SOPHiA GENETICS To Lead Panel on Artificial Intelligence, Multimodal Data, and its Role in Medicine at BioData World Congress on Nov. 9, 2022
BASEL, Switzerland - October 31, 2022 — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software...
Ontario Group of Hospitals use a future-proof custom SOPHiA DDM™ Comprehensive Hereditary Cancer Solution to be in line with Ontario guidelines.
Hospitals maximize efficiency of their laboratory workflow, fulfil updated Ontario guidelines and keep testing in-house.
How the Future of Genomic Analysis is Already Furthering Breast Cancer Research
The advancement of genomic analysis technology revolutionizes breast cancer research, as it provides better breast tumor classifications, which then leads to enhanced clinical management or precision oncology.
Somatic RNA variant calling in solid tumors
About Gene fusions are the latest type of biomarker to receive broad applicability in cancer...
White Paper: Performance Evaluation of the CE-IVD SOPHiA DDM™️ Dx RNAtarget Oncology Solution (ROS)
Read our SOPHiA DDM™️ Dx ROS performance evaluation study and make confident data-driven decisions that improve patient care.
Raising Awareness of Familial Hypercholesterolemia (FH)
Studies show that as few as 10% of people living with familial hypercholesterolemia (FH) could be aware of their diagnosis. Could genetic testing expedite early diagnosis and timely treatment?
Food for thought from ESMO 2022: the journey towards personalized therapy
Last week we attended the European Society for Medical Oncology (ESMO) Congress 2022, gathering the world’s leading oncologists. Read our summary of three presentations illustrating cancer therapy development.
SOPHiA GENETICS Unveils Strategy to Drive Health Care Innovations at Inaugural Investor Day Event
Highlights include: a memorandum of understanding with Memorial Sloan Kettering Cancer Center and...
World GO Day Raising Awareness for Gynaecological Cancers
With over 1.3 million women worldwide diagnosed with gynaecological cancers in 2020, it’s more important now than ever to equip them with tools and resources to promote prevention and early detection of potential cancers.